Exceptional pathologic response to preoperative therapy in the context of mutational profiling for colorectal liver metastases

J Gastrointest Surg. 2024 Jul;28(7):1181-1184. doi: 10.1016/j.gassur.2024.05.002. Epub 2024 May 7.

Authors

Mateo Lendoire¹, Harufumi Maki¹, Antony Haddad¹, Timothy E Newhook¹, Ching-Wei D Tzeng¹, Jean-Nicolas Vauthey¹, Hop S Tran Cao²

Affiliations

¹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
² Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States. Electronic address: hstran@mdanderson.org.

PMID: 38723997
DOI: 10.1016/j.gassur.2024.05.002

No abstract available

Keywords: Colorectal liver metastases; Exceptional pathologic response; Pathologic response; Preoperative chemotherapy.

Publication types

Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Colorectal Neoplasms* / genetics
Colorectal Neoplasms* / pathology
Hepatectomy / methods
Humans
Liver Neoplasms* / genetics
Liver Neoplasms* / secondary
Liver Neoplasms* / surgery
Middle Aged
Mutation
Neoadjuvant Therapy / methods
Proto-Oncogene Proteins B-raf / genetics

Substances

Proto-Oncogene Proteins B-raf